Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 16 - Number 22


Safeguarding Childrens Rights in Psychopharmacological Research: Ethical and Legal Issues

, 16(22): 2398 - 2406

Michael Kolch, Andrea G. Ludolph, Paul L. Plener, Heiner Fangerau, Benedetto Vitiello and Joerg M. Fegert


DOI: 10.2174/138161210791959881





What can Actigraphy Add to the Concept of Labschool Design in Clinical Trials?

, 16(22): 2434 - 2442

Henrik Uebel, Bjorn Albrecht, Roumen Kirov, Alexander Heise, Manfred Dopfner, Franz Joseph Freisleder, Wolff Dieter Gerber, Michael Gunter, Frank Hassler, Claudia Ose, Fritz Poustka, Roland Fischer, Tobias Banaschewski and Aribert Rothenberger


DOI: 10.2174/138161210791959845






Targeting the p53 Pathway of Apoptosis

, 16(22): 2493 - 2503

Joana D. Amaral, Joana M. Xavier, Clifford J. Steer and Cecilia M.P. Rodrigues


DOI: 10.2174/138161210791959818



Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog